Compumedics Limited (ASX:CMP)

Market Cap	52.81M
Revenue (ttm)	51.04M
Net Income (ttm)	-1.27M
Shares Out	192.04M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	10.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	153,600
Average Volume	108,591
Open	0.2800
Previous Close	0.2650
Day's Range	0.2750 - 0.2800
52-Week Range	0.2400 - 0.3650
Beta	0.45
RSI	42.23
Earnings Date	Aug 28, 2025

About Compumedics

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Okti; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; Somté, an investigative tool; Siesta 802; and Somté PSG. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's hom...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 155
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CMP

Financial Performance

In 2025, Compumedics's revenue was 51.04 million, an increase of 1.55% compared to the previous year's 50.26 million. Losses were -1.27 million, 276.3% more than in 2024.